Alvotech (ALVO) Free Cash Flow (2021 - 2026)
Alvotech (ALVO) posted Free Cash Flow of -$53.3 million for Q1 2026, down 163.0% on a QoQ basis from $84.6 million in Q4 2025, and down 249.11% year-over-year from $35.7 million in Q1 2025.
Alvotech (ALVO) Free Cash Flow (2021 - 2026) Analysis & Trends
Alvotech's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$53.3 million for Q1 2026.
- Quarterly Free Cash Flow fell 249.11% year-over-year to -$53.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$146.3 million (up 41.38% YoY) and the FY2025 annual result came in at -$57.3 million, up 80.27% from the prior year.
- Free Cash Flow was -$53.3 million for Q1 2026 at Alvotech, down from $84.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $84.6 million in Q4 2025 and bottomed at -$279.0 million in Q4 2023.
- A 5-year average of -$84.5 million and a median of -$57.8 million in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 256.23% in 2025, while the deepest fall reached 327.19% in 2025.
- Alvotech's Free Cash Flow stood at -$274.5 million in 2022, then retreated by 1.62% to -$279.0 million in 2023, then surged by 34.33% to -$183.2 million in 2024, then surged by 146.18% to $84.6 million in 2025, then tumbled by 163.0% to -$53.3 million in 2026.
- Business Quant data shows ALVO's Free Cash Flow at -$53.3 million in Q1 2026, $84.6 million in Q4 2025, and -$247.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -53.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.29 Mn |
| Mar 31, 2026 | -53.29 Mn |
| Dec 31, 2025 | 84.59 Mn |
| Dec 31, 2025 | 84.59 Mn |
| Sep 30, 2025 | -247.01 Mn |
| Sep 30, 2025 | -247.01 Mn |
| Jun 30, 2025 | 69.36 Mn |
| Jun 30, 2025 | 69.36 Mn |
| Mar 31, 2025 | 35.74 Mn |
| Mar 31, 2025 | 35.74 Mn |
| Dec 31, 2024 | -183.18 Mn |
| Dec 31, 2024 | -183.18 Mn |
| Sep 30, 2024 | -57.82 Mn |
| Sep 30, 2024 | -57.82 Mn |
| Jun 30, 2024 | -44.40 Mn |
| Jun 30, 2024 | -44.40 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Dec 31, 2023 | -278.95 Mn |
| Dec 31, 2023 | -278.95 Mn |